BioSpace News Archive

On December 15, 2020, Professor Wang Jian’an’s team from the Second Hospital of Zhejiang University School of Medicine successfully applied the DragonFly-T™ Transcatheter Tricuspid Valve Clamping System to perform the first human clinical application in mainland China.

Nordic Capital and Astorg Invest in Pharmaceutical Technology and Advanced Analytics Company Cytel Cytel is one of the leading global providers of clinical trial design technology, biometric services and advanced analytics, focusing on optimizing clinical trials and helping pharmaceutical companies to unlock the full potential of their clinical and real-world data

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“the Company” or “RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration, issued a year-end Letter to Stockholders. The Letter may be viewed

Vuzix® Corporation (NASDAQ: VUZI), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, has announced that the Vuzix Blade® Smart Glasses was used to aid the first AR total knee replacement surgery conducted in the United States.

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion to recommend the conditional marketing authorization (CMA) of the Pfizer-BioNTech COVID-19 Vaccine (also known as BNT162b2), f

Medexus Pharmaceuticals (MDP.V) is a specialty pharmaceuticals company that delivers innovative medicines to underserved segments of the market. With over 20,000 prescription drug products approved for marketing in North America , the pharmacology space is fiercely competitive. Identifying “

The funding round was spearheaded by US based Rhia Ventures, Astia angels and existing investors Pontifax VC to bring OCON’s first ever 3D long-term intrauterine contraceptive to the US market

Olympus announced today the first patient enrolled in an international study to collect real-world evidence on the performance of the new SOLTIVE ™ Premium SuperPulsed Laser System

Peptilogics announced today the closing of a $35.4 million Series B financing. The financing was led by Presight Capital, with participation from a new investor syndicate including Founders Fund as w

exocad GmbH, an Align Technology, Inc. company, announced the availability of exoplan 3.0 Galway, the latest version of its implant planning software.